Medavante: Subjective > Objective
Corporate Headquarters
100 American Metro Boulevard
Suite 106
Hamilton, NJ 08619
609.528.9400
609.528.9400     
Scales being administered: HAMD, MADRS, SIGHADS, SCID, ACDS, PANSS, CDSS, CGI-S, CDRS-R, QLS, PSP, IDCS, SAPS
 
Home Services Team Research eLearning News & Press Careers FAQs Links Contact
World Map Graphic MedAvante administers clinical assessments for research studies to 94 investigative sites active across North America.  MedAvante conducts Global Rater Training — Rater Readiness in 14 countries throughout the
 
Tom Laughren, M.D., Director, Division of Psychiatry Products, FDA, Commentary on Centralized Ratings at NCDEU 2008

MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures

MedAvante's Centralized Expert Ratings Services provide pharmaceutical companies with faster, more cost effective, more confident decision-making regarding drug trials.

» TUTORIALS

MedAvante's Mission:

MedAvante's mission is to bring better and safer CNS drugs to market faster by delivering high quality assessments for clinical trials.

MedAvante is a pharmaceutical services organization whose commitment and passion is to improve the science of psychiatric drug trials. The cornerstone of our success is MedAvante's Centralized Expert Ratings Services through which highly trained interviewers administer clinical assessments for research studies via videoconference and telephone. Centralizing the assessments increases the precision, accuracy, reliability and quality of the administration of psychiatric diagnostic and symptom assessments.

MedAvante's scientific leadership includes thought leaders in psychiatric assessment and clinical trials from academia and leading global pharmaceutical companies. Each MedAvante senior scientist has engaged in funded research examining improved assessment methodologies, has authored psychiatric scales or has led efforts to update current scales. Our senior scientists train site-based raters for our Global Rater Training Program-Rater ReadinessTM in order to ensure research quality for study sponsors.